Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment?

Radiation injury vs. recurrent brain metastasis: combining textural feature radiomics analysis and standard parameters may increase 18F-FET PET accuracy without dynamic scans

(2016) Philipp Lohmann et al.   EUROPEAN RADIOLOGY

Serial 18F-FET PET Imaging of Primarily 18F-FET-Negative Glioma: Does It Make Sense?

(2016) M. Unterrainer et al.   JOURNAL OF NUCLEAR MEDICINE

Amino acid PET for brain tumours — ready for the clinic?

(2016) Karl-Josef Langen et al.   Nature Reviews Neurology

PET imaging in glioma: is it time for mainstream practice?

(2016) Colin Watts et al.   NEURO-ONCOLOGY

Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas

(2016) Nathalie L. Albert et al.   NEURO-ONCOLOGY

Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume

(2016) Marc D. Piroth et al.   Radiation Oncology

Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties?

(2016) Alexander Romagna et al.   Radiation Oncology

Dual-time-point O-(2-[18F]fluoroethyl)-L-tyrosine PET for grading of cerebral gliomas

(2015) Philipp Lohmann et al.   EUROPEAN RADIOLOGY

Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET

(2014) Norbert Galldiks et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prognostic Significance of Dynamic 18F-FET PET in Newly Diagnosed Astrocytic High-Grade Glioma

(2014) N. L. Jansen et al.   JOURNAL OF NUCLEAR MEDICINE

Impact of [18F]-fluoro-ethyl-tyrosine PET imaging on target definition for radiation therapy of high-grade glioma

(2014) P. Munck af Rosenschold et al.   NEURO-ONCOLOGY

Dynamic 18F-FET PET in Newly Diagnosed Astrocytic Low-Grade Glioma Identifies High-Risk Patients

(2013) N. L. Jansen et al.   JOURNAL OF NUCLEAR MEDICINE

[18F]-fluoro-ethyl-l-tyrosine PET: a valuable diagnostic tool in neuro-oncology, but not all that glitters is glioma

(2013) Markus Hutterer et al.   NEURO-ONCOLOGY

MRI-suspected low-grade glioma: is there a need to perform dynamic FET PET?

(2012) Nathalie L. Jansen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI

(2012) Norbert Galldiks et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis

(2012) N. Galldiks et al.   JOURNAL OF NUCLEAR MEDICINE

O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma

(2011) M. Hutterer et al.   JOURNAL OF NUCLEAR MEDICINE

German guidelines for brain tumour imaging by PET and SPECT using labelled amino acids

(2011) K.-J. Langen et al.   NUKLEARMEDIZIN-NUCLEAR MEDICINE

FET–PET for malignant glioma treatment planning

(2011) Maximilian Niyazi et al.   RADIOTHERAPY AND ONCOLOGY